GlassScriptPhysician profile
Matthew Alan Varacallo
NPI 1629415682
$129,195.12
in general payments reported to CMS, 2019-2025
37 companies · $34K in 2025
The $34K reported for 2025 was more than what 94% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $2,272 · 2021: $11K · 2022: $1,920 · 2023: $36K · 2024: $27K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $65K · Travel and Lodging: $17K · Food and Beverage: $7,872 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,800 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,765.37 |
| Travel and Lodging | $16,563.15 |
| Food and Beverage | $7,871.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,800.00 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $28,545.97 | 2023-2025 | Vistaseal, Stratafix, Dermabond Prineo |
| Smith+Nephew, INC. | $24,137.25 | 2019-2025 | Na, Stravix, Stravix Pl |
| Ethicon US, LLC | $19,698.43 | 2022-2025 | Vistaseal, Stratafix, Dermabond Prineo |
| Arthrex, INC. | $16,301.09 | 2019-2025 | |
| Pacira Pharmaceuticals Incorporated | $12,274.64 | 2020-2025 | Exparel, Iovera, Zilretta |
| Mid-Atlantic Surgical Systems, LLC | $10,823.67 | 2019-2025 | |
| Stryker Corporation | $6,553.07 | 2019-2025 | System 9 Cd Nxt, Mako, Triathlon |
| Hydrocision, INC. | $5,063.37 | 2023-2024 | Tenjet |
| Exactech, INC. | $1,499.86 | 2019 | |
| Zimmer Biomet Holdings, INC. | $979.60 | 2019-2020 | |
| Wright Medical Technology, INC. | $907.17 | 2019 | |
| Pacira Therapeutics, INC. | $397.37 | 2019-2021 | |
| Lazurite INC. | $279.59 | 2023 | |
| Medtronic, INC. | $251.96 | 2022-2025 | Aquamantys(Tm), Inceptiv |
| Coastal Medical Technologies LLC | $197.85 | 2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Orthopaedics, INC. | $178.92 | 2024 | Integrity Orthopaedics |
| Cumberland Pharmaceuticals, INC. | $159.54 | 2023-2025 | Caldolor |
| Medacta USA, INC. | $101.03 | 2022 | |
| Ferring Pharmaceuticals INC. | $96.55 | 2023-2024 | Euflexxa |
| Medtronic USA, INC. | $87.68 | 2019 | |
| Vericel Corporation | $76.67 | 2023 | Maci |
| Curonix LLC | $72.50 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Depuy Synthes Sales INC. | $60.95 | 2024-2025 | Monovisc, Orthovisc |
| Vertex Pharmaceuticals Incorporated | $60.88 | 2025 | |
| Organogenesis INC. | $57.66 | 2023 | Puraply |
| Novo Nordisk INC | $47.08 | 2025 | Wegovy |
| Change Healthcare Technologies, LLC | $46.14 | 2021 | |
| Solventum Corporation | $40.50 | 2024-2025 | 3m Cavilon, Activ.A.C., Prevena |
| Becton, Dickinson and Company | $37.15 | 2025 | Channel Drain |
| Medline Industries LP | $25.93 | 2025 | |
| Skeletal Dynamics INC | $22.15 | 2023 | Implate, Align, Geminus |
| Horizon Therapeutics Plc | $21.64 | 2022 | |
| Acera Surgical, INC. | $20.57 | 2025 | Restrata Wound Matrix |
| Heraeus Medical, LLC. | $18.98 | 2025 | |
| Trice Medical, INC. | $18.77 | 2022 | |
| Janssen Biotech, INC. | $18.76 | 2025 | Simponi, Tremfya, Stelara |
| Endo Pharmaceuticals INC. | $14.18 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$200,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Varacallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.